Le Lézard
Classified in: Health
Subject: SVY

2020 Small Molecule API Contract Manufacturer Quality Benchmarking, 5th Edition - Current Outsourcing Trends & Practices, Quantitative Analysis of CMO Service Quality


DUBLIN, March 6, 2020 /PRNewswire/ -- The "Small Molecule API Contract Manufacturer Quality Benchmarking (5th Edition)" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

Small Molecule API Contract Manufacturing Quality Benchmarking brings with it a wealth of knowledge and information created with two goals in mind, help biopharmaceutical companies make more informed CMO decisions, and help CMOs optimize operational and marketing strategies.

This report provides pharmaceutical companies and contract manufacturers a comprehensive analysis of current outsourcing trends and practices, in addition to a quantitative analysis of CMO service quality across a series of 22 performance attributes specific to outsourced drug substance manufacturing. In this Consumer Report-style analysis, the publisher presents data on 455 service encounters from 158 respondents who have been involved in outsourced small molecule API projects in the past 18 months.

What You Will Learn

Drug Developers

Contract Manufacturers

Major Topics

Key Topics Covered

1. Outsourcing Philosophies and Practices

2. CMO Selection Drivers

3. CMO Perceptions and Interactions

4. CMO Performance and Loyalty

5. Small Molecule API CMO Competitive Landscape

6. Study Data

7. Demographics

For more information about this report visit https://www.researchandmarkets.com/r/kbu00s

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 20:31
Fitness International, LLC opened a new Club Studio location in Kingwood, Texas. The new 40,000 square foot club features five innovative boutique fitness studios that were carefully curated to create a unique experience, along with recovery services...

at 19:35
Mirum Pharmaceuticals, Inc. today announced that on May 10, 2024, the Compensation Committee of Mirum's Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 38,600 shares of common stock and 19,300...

at 19:00
Evolus, Inc. , a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant of non-qualified stock options to purchase an aggregate of 10,990 shares of Evolus and an aggregate of 42,759...

at 18:36
Inhibrx, Inc. ("Inhibrx," or the "Company") today announced that in connection with the previously announced distribution by the Company of 92% of shares of common stock of its subsidiary Inhibrx Biosciences, Inc. ("SpinCo") to holders of shares of...

at 17:55
Asia Green Biotechnology Corp. ("Asia Green" or the "Company") announces that, further to its news releases dated April 17, 2024, April 26, 2024, and May 8, 2024, the Management Cease Trade Order ("MCTO") issued by the...

at 17:53
The following statement is being issued by Rice Harbut Elliott LLP regarding the Ruckman v. Biotrade Canada Ltd. et al. lawsuit: All persons in Canada who purchased or ingested U-Dream on or after August 18, 2014 (the "Class" or "Class Members")...



News published on and distributed by: